Nu Skin (NUS) Q1 2026 earnings review
Core Network Collapses as Management Sells the Future
Nu Skin's first quarter delivered a brutal reality check against management's optimistic transition narrative. Revenue fell 12% YoY to $320.6M, marking the fifth consecutive quarter of double-digit contraction. More alarmingly, the underlying sales engine is eroding fast: total customers dropped 14% to a multi-year low of 669K, and the sales leader count fell 13%. While management continues to hype the upcoming H2 consumer rollout of the Prysm iO intelligent wellness platform and a late-2026 India expansion, the core business lacks stability. With adjusted operating margins compressing to 3.6% and guidance pointing to continued top- and bottom-line erosion, the company is racing against the clock to pivot before its distribution network hollows out entirely.
🐂 Bull Case
The company is actively flushing out low-margin, legacy beauty revenue in favor of high-LTV wellness subscriptions. The planned H2 2026 full consumer rollout of the Prysm iO AI platform could reignite distributor excitement.
Despite operational weakness, the company has successfully deleveraged over the past year (reducing debt significantly since early 2025) and maintained a net cash positive position, ensuring they can fund the India and Prysm iO initiatives without distress.
🐻 Bear Case
A direct-selling model cannot function without sellers. The continued 13% YoY loss in Sales Leaders and 8% loss in Paid Affiliates limits the funnel for any new product launches, making a back-half recovery highly questionable.
The Rhyz segment, previously touted as a key growth driver and diversification engine (+17% YoY in 25Q2), suddenly saw manufacturing revenues plunge 18.7% YoY in Q1, stripping the company of its only growing pillar.
⚖️ Verdict: 🔴🔴
Highly Bearish. When management cites 'early signs of improving paid affiliates' while the printed data shows a 14% sequential drop in total customers and a YoY contraction in every major region, credibility is strained. The core business is shrinking faster than the new initiatives can scale.
Key Themes
Narrative vs. Reality on Sales Force Health
Management explicitly stated they are 'encouraged by early signs of improving paid affiliates and new sales leader development.' This directly contradicts the printed financials: Paid Affiliates dropped 8% YoY (and fell from 129,311 in 25Q4 to 120,850 in 26Q1) while Sales Leaders dropped 13% YoY. A sequential loss of roughly 8,500 affiliates and 3,100 leaders in a single quarter is a massive red flag that casts doubt on the 'improving' narrative.
Rhyz Manufacturing Growth Reverses
For the past year, the Rhyz Manufacturing segment was management's reliable bright spot, consistently growing (+17.3% in 25Q2, for instance) and validating the incubator strategy. In 26Q1, that trend is Reversing violently. Rhyz Manufacturing revenue fell 18.7% YoY to $44.9M. If external partner demand is drying up, Nu Skin is left entirely reliant on its contracting direct-sales channel.
Prysm iO as the Make-or-Break Catalyst
The entire strategic pivot rests on Prysm iO, an AI-powered intelligent wellness platform. Management is currently equipping sales leaders with the device to build the nutritional health biomarker database ahead of a full consumer rollout in H2 2026. The thesis: use hardware to drive high-LTV wellness product subscriptions. If successful, this could transform Nu Skin from a transactional cosmetics company to a recurring-revenue wellness platform.
Severe Deterioration in the Americas and South Korea
Geographic performance remains bleak. South Korea was the worst laggard, plunging 22.1% YoY to $25.3M (with customers down 20%). The Americas, historically a core stronghold, dropped 16.3% to $57.8M (customers down 18%). The continued erosion of the Americas footprint suggests deep systemic issues with the compensation model or brand resonance in developed, hyper-competitive social commerce markets.
India Market Expansion Delayed Impact
Management continues to highlight India (a 1.4 billion population market) as a massive structural growth opportunity. However, they clarified that the formal launch is not anticipated until late 2026. While strategically sound, this means investors cannot expect any meaningful revenue rescue from India during the current fiscal year.
Other KPIs
Decelerating sharply from 6.4% in 25Q1. While adjusted gross margins held perfectly steady (67.9% vs 67.8%), operating deleverage crushed the bottom line. Selling expenses rose to 34.3% of revenue (up from 32.5%), and adjusted G&A rose to 29.9% (up from 28.9%). The company is losing scale faster than it can cut costs.
Stable. The company paid $2.9M in dividends and executed $5.0M in stock repurchases. While mathematically sound given their cash balance, buying back stock when the distributor network is actively imploding raises questions about capital allocation priorities versus investing in network stabilization.
Guidance
Stable trajectory. The midpoint of $345M implies a YoY decline of roughly 11% (vs 25Q2's $386.1M) and roughly 0% FX impact. This indicates management does not expect any meaningful sequential rebound in the core business before the H2 launches.
Decelerating. Compared to 25Q2's adjusted EPS of $0.43, this represents a severe YoY profit contraction. It reflects the ongoing deleverage from lower sales volumes and the absence of margin support from the Rhyz Manufacturing segment.
Stable. Management maintained their full-year guide, which implies a range of -9% to +1% YoY growth. Achieving the higher end of this range mathematically requires a massive, unprecedented revenue acceleration in the second half of the year. Given current run-rates, reaching the midpoint relies heavily on Prysm iO execution.
Reiterated, but requires a steep back-half ramp. In prior quarters, management noted that 2026 EPS will be heavily pressured by an effective tax rate spike to roughly 35% (compared to 2025's tax-advantaged ~19%).
Key Questions
Affiliate Growth Discrepancy
You noted 'early signs of improving paid affiliates' in your prepared remarks, yet the reported data shows Paid Affiliates are down 8% YoY and dropped sequentially by over 8,000. In which specific markets are you seeing these improvements, and why aren't they offsetting the broader collapse?
Rhyz Manufacturing Reversal
Rhyz Manufacturing went from a double-digit growth engine last year to an 18.7% YoY decline this quarter. Did you lose a major third-party customer, or is this a broader slowdown in the external beauty manufacturing space?
H2 Execution Risk
Your FY26 revenue guidance relies entirely on a second-half inflection driven by Prysm iO. With total customers and sales leaders at multi-year lows, how will you effectively distribute and scale a new hardware platform through a rapidly shrinking network?